Cargando…
Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine
OBJECTIVE: For diagnosis and treatment in the acute setting, it is crucial to know whether the clinical status of patients might be explained by the effects of drugs. The objective of this study was to determine how many drugs were detected by comprehensive toxicological screening, that could not be...
Autores principales: | van der Schaar, J.A.J., Attema-de Jonge, M.E., Gresnigt, F.M.J., Franssen, E.J.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184233/ https://www.ncbi.nlm.nih.gov/pubmed/32368504 http://dx.doi.org/10.1016/j.toxrep.2020.04.007 |
Ejemplares similares
-
Clinical value of drugs of abuse point of care testing in an emergency department setting
por: Lager, P.S., et al.
Publicado: (2017) -
Complications in post-mortem GHB cut-off values in urine samples: A case report
por: Loos, N.H.C., et al.
Publicado: (2023) -
Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
por: van der Pas, R.S.D., et al.
Publicado: (2020) -
Toxicological Characterization of GHB as a Performance-Enhancing Drug
por: Giorgetti, Arianna, et al.
Publicado: (2022) -
Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
por: Tay, Emma, et al.
Publicado: (2022)